Anthropic plans to list on Nasdaq, seeking a $1.4 trillion valuation
Anthropic is expected to list on Nasdaq on Thursday, planning to seek a $1.4 trillion valuation in its IPO and, together with a separate private placement, raise up to $90.4 billion. As of October 31, its annualized revenue reached $81 billion, an increase of $10 billion from the end of September, and Goldman Sachs analysts expect the company will not achieve positive annual free cash flow until 2030. The IPO has already been nearly seven times oversubscribed, and the market views it as a new bellwether for measuring progress in AI commercialization.
Why read this
AI score 88
The original article places Anthropic's IPO valuation, financing scale and revenue data in the context of Nvidia's leadership transition, allowing readers to observe the shift in the focus of the AI commercialization narrative.
Topics
Body · AI translation
Anthropic is expected to list on Nasdaq on Thursday, which will not only put pressure on its CEO Dario Amodei to fill the void left by Jensen Huang as the AI industry's top spokesman, but will also require the company to prove that the AI gold rush has moved beyond the "selling shovels" stage, as Wall Street begins to focus on who can actually use these tools to make money (actually strike gold). It was precisely by selling these tools that Nvidia once became a $5.8 trillion company.
This will require some patience from the investment community, a circle known for its fixation on short-term performance. Estimates from Goldman Sachs Group analysts show that Anthropic is not expected to achieve positive annual free cash flow until 2030, while the AI company's spending commitments through 2045 exceed $900 billion.
With the future of data center construction tightly bound to circular deals, Nvidia is providing financing to Anthropic and other major users of its AI chips. Questions are being raised about whether the chipmaker's new leadership will have the same risk tolerance as Jensen Huang.
Anthropic's fundraising to exceed SpaceX's
Last Friday, at an IPO event held at JPMorgan's new headquarters in New York, Amodei pitched alongside JPMorgan CEO Jamie Dimon and appeared to successfully block out all the external noise. He wore his signature running shoes, white socks and a blue blazer.
"We don't particularly care about the specific listing timing, which month, which day, or what the market environment is like at the time of listing," Amodei told Dimon at the event. Attendees included prominent fund managers such as Paul Singer, Bill Ackman and Ron Baron.
Amodei also revealed that throughout the listing preparation process, the best advice he received was: "Never let the company's valuation be even $1 higher than its actual value."
For Wall Street investors who have been trying to figure out how many dollars Anthropic is actually worth, the upcoming IPO is not only a vote of confidence by Anthropic in its own prospects, but also a guarantee: the entire AI investment boom will continue, only the leader will be a new company.
"This IPO is extremely important because Anthropic may be the best gauge of the health of the entire AI ecosystem. Their views on how to monetize AI are now, in my view, no less important than—perhaps even more important than—Nvidia's, after all, Jensen Huang is no longer at the helm," said Angelo Zino, senior vice president and head of technology research at investment research firm CFRA.
Amodei
Anthropic plans to seek a $1.4 trillion valuation in the IPO, far below the $2 trillion proposed by the market a few months ago, but far above the $1.1 trillion valuation proposed by some on Wall Street when the recent tech stock selloff was at its worst.
Anthropic and some of its backers hope to raise up to $90.4 billion in total through the IPO and a separate private placement. If the two fundraisings are combined, the scale would exceed SpaceX's $75 billion base fundraising at the time of its IPO, making it the largest listing transaction in history.
The deal has been enthusiastically sought after by investors. People familiar with the matter said the IPO has already been nearly seven times oversubscribed. One of the people said market demand at this stage is far stronger than at the time of SpaceX's IPO. The person said the only comparable case was software company Snowflake's $3.9 billion IPO in 2020, when the company's stock price surged 112% on its first trading day.
Anthropic is less than six years old, yet the scale of revenue it has generated is already quite astonishing. As of October 31 this year, the company's annualized revenue (the full-year revenue level extrapolated from revenue over a shorter period) reached $81 billion, an increase of $10 billion from the end of September. If Anthropic can achieve this annual revenue scale, it will join the ranks of the few companies globally with revenue at this level, even exceeding analysts' revenue expectations for giants such as Intel and ASML that provide hardware support for the AI boom.
"Public market investors are racking their brains trying to figure out just how big AI demand really is, which is why everyone is paying close attention to the ARR (annual recurring revenue) data released at the end of each month," said Matt Witheiler, head of late-stage growth investing at Wellington Management, which holds Anthropic shares. "There is currently no metric for measuring AI demand in the public market, because these companies have previously been private. But as Anthropic becomes the first to enter the public capital markets, that will change."
Anthropic's current spending has not yet put pressure on its cash reserves. The company still holds more than $130 billion in cash and cash equivalents on its books, while its cumulative fundraising total is about $141 billion. However, that situation is not expected to last, because the company has a large number of spending commitments to fulfill in the coming years. Of that, about $71 billion in spending will come due before the end of September 2027.
“Increasingly fierce price competition may make it harder for the company to maintain gross margins. They must also generate enough enterprise-level token consumption and make enough money to cover these infrastructure investment commitments,” said Bloomberg Intelligence analyst Mandeep Singh.
The difference between Amodei and Jensen Huang
However, tech stocks have suffered a sharp selloff over the past month. Even after the U.S. midterm elections ended, the AI investment boom struggled to shake off the dark clouds. The election results will put the next Congress under the control of Democrats hostile to the tech industry, and combined with Jensen Huang's forced departure, market uncertainty has further intensified.
Jensen Huang
These explosive developments sent Nvidia's stock sharply lower, marking its worst week since the market selloff triggered by Trump's tariff policy in April 2025. At the same time, these events have prompted Wall Street to undertake a major reassessment of the future of the AI industry. This has further increased pressure on Anthropic, with the market expecting the company to reignite investor optimism about the technology.
If tech stocks begin to fluctuate in the future and the market turns to Amodei rather than Jensen Huang for confidence, investors will see a stark contrast between the two: on one side, the Nvidia CEO who frequently travels the world, has a star-like presence and wears his signature Tom Ford black leather jacket; on the other, the low-key, scholarly co-founder of Anthropic.
Last week, the differences between the two companies and their leaders became even more apparent. According to people familiar with the matter, Anthropic did not allow institutional investors from mainland China and Hong Kong to subscribe to this IPO. By contrast, Jensen Huang has been actively pushing Nvidia products into the Chinese market and working to build close ties with China.
Anthropic's advantages
Beyond Nvidia's own problems, as investors shift their focus from the chips and infrastructure needed to run AI technology to companies developing agents and chatbots (the products that will ultimately carry AI into real-world use), Anthropic may be better suited to serve as a bellwether for the AI industry's development.
“Market expectations are clear, and they are very high. The question is whether the company can stay on the trajectory needed to meet those expectations?” said Mike Smith, head of the growth equity team at Allspring Global Investments. “Unfortunately for them, trillions of dollars are resting on their shoulders. It is one of the key bellwethers for whether AI commercialization can succeed.”
Kim Forrest, chief investment officer at investment advisory firm Bokeh Capital Partners, said: “Anthropic may become the most important company in the public market, because it will be the quintessential representative of AI's commercial application. In fact, from the very beginning, everyone's attention should have been on the companies that use AI and the companies that use AI chips.”
This week, the market's attention will undoubtedly be focused on Anthropic's listing. The Wall Street banks leading the IPO, Goldman Sachs and Morgan Stanley, are expected to stop accepting investor subscription orders on Tuesday. Ironically, that is also the day Nvidia will release its first earnings report and hold a conference call after Jensen Huang stepped down as CEO.
Anthropic will become one of the highest-market-cap stocks in the U.S.
Given Anthropic's enormous influence in the market, the share allocation method and final offering price of its IPO will have a crucial impact on the entire market.
After listing, Anthropic's quarterly earnings reports will become an important basis for the market and the global economy to understand the progress of AI development. Allspring's Smith said: “In my view, nothing is more important right now than observing whether the infrastructure that has already been built can actually be commercialized. To make all of this truly work, they must generate more revenue than anyone else within two to three years.”
This is undoubtedly a daunting task, but investors appear willing to bet that Amodei's dreams will continue to become reality. Those dreams include not only improving productivity in everyday business work, but also grander goals, such as ridding the world of major diseases.
Last Friday, speaking with Dimon, Amodei said: “I hope we can ultimately prove the skeptics wrong and enable humanity to view all the diseases you can think of the way we view plague or smallpox today: heart disease, Alzheimer's disease, cancer, as things of the past. This may sound overly idealistic, even a little crazy, but I truly believe, I truly believe this can be done.”